Stock Market Update - February 3, 2026
Today's stock market saw some significant movers. Here's a breakdown of 5 stocks that caught our attention:
1. SXTC - China SXT Pharmaceuticals, Inc.
Price: $4.53 | Change: +10410.44% ($4.4869)
SXTC saw an eye-popping 10410.44% gain, making headlines. This dramatic surge for China SXT Pharmaceuticals, Inc. was primarily driven by a 1-for-150 reverse stock split that became effective on February 3, 2026. This corporate action drastically reduced the number of outstanding shares, thereby mathematically increasing the price of each remaining share.
Prior to the split, the company had over 143 million shares outstanding, which was reduced to approximately 957,960 after the consolidation. While the news of the split was announced earlier, the stock saw a significant pre-market increase leading up to its effective date, ultimately closing at $5.08 per share post-split.
Companies often undertake reverse stock splits to boost their per-share price, a common move to help them comply with exchange minimum bid price requirements, such as those set by Nasdaq, and to enhance their stock's market presence. It's key to remember that a reverse split doesn't inherently change the company's overall market capitalization; it simply consolidates existing value into fewer, higher-priced shares.
2. TIRX - Tian Ruixiang Holdings Ltd
Price: $0.15 | Change: +98.41% ($0.0744)
TIRX surged an impressive 98.41% following news of a transformative strategic partnership and a substantial Bitcoin injection. On February 3, 2026, Tian Ruixiang Holdings Ltd announced a definitive agreement with a prominent global digital asset investor. Under this landmark deal, the investor will inject 15,000 Bitcoins (BTC) into TIRX, valued between USD 1.1 billion and USD 1.5 billion, in exchange for a significant equity stake.
This massive Bitcoin infusion is earmarked to fund a joint global innovation lab. The lab will focus on developing cutting-edge AI-crypto products, advanced trading systems, and solutions for decentralized finance (DeFi) and non-fungible tokens (NFTs). Company management emphasized that this move will significantly bolster TIRX's balance sheet and accelerate its research and global expansion strategies.
What's particularly interesting is how this agreement positions Tian Ruixiang at the heart of the converging artificial intelligence and cryptocurrency ecosystems. This strategic pivot aims to make TIRX a key player in these rapidly evolving sectors, building on earlier discussions to acquire an AI and crypto insurance broker.
3. LIMN - Liminatus Pharma, Inc. Class A Common Stock
Price: $1.07 | Change: +87.36% ($0.4989)
LIMN shot up by an impressive 87.36%. This significant jump was primarily a strategic effort to regain compliance with Nasdaq's minimum bid price rule. Liminatus Pharma's stock had previously fallen below the required $1 closing price for an extended period, risking delisting. The recent surge, including a strong after-hours rise, pushed the stock price back above $1, helping the company meet its July 2026 deadline to avoid delisting.
Adding to this renewed optimism, an earlier $30 million equity investment from Capital Trust Group (announced October 2025) provides a positive financial outlook, aiming to fund Liminatus Pharma's immunotherapy research. This combination of a concerted effort to secure its continued exchange listing and a fresh capital injection for future development makes LIMN's recent movement particularly noteworthy.
4. WTO - UTime Limited
Price: $1.1 | Change: +83.18% ($0.4995)
WTO (UTime Limited) recently caught investors' eyes with an impressive 83.18% gain. This significant movement followed the announcement of a strategic cooperation agreement that could reshape the company's future.
The surge came after UTime's Shenzhen-based subsidiary revealed a deal to potentially supply 500,000 advanced smart servers to Shenzhen Yunwei Digital Technology Co., Ltd. Valued at approximately US$50 million, these high-performance GM800 servers represent a substantial potential revenue stream.
The company's CEO emphasized this as a transformative step, signaling UTime's entry and expansion into the growing enterprise and cloud infrastructure market. With initial deliveries anticipated to begin swiftly and continue through 2027, this agreement highlights the company's ambition to establish a substantial presence in a new, high-growth sector.
5. GXAI - Gaxos.ai Inc.
Price: $2 | Change: +41.84% ($0.59)
GXAI soared over 41% around February 4, 2026, thanks to a significant strategic collaboration with Amazon Web Services (AWS).
Gaxos.ai announced that AWS has committed to funding the preliminary development of Gaxos Labs, an innovative AI-powered sales coaching platform. This new platform, built on AWS infrastructure, aims to deliver real-time AI sales tools like live call transcription, automated coaching, and post-call analytics.
This commitment from a tech giant like AWS is a substantial validation for Gaxos.ai's technology and its potential to enter the multibillion-dollar sales technology market. Investors clearly reacted positively to this partnership, seeing it as a strong sign of increased credibility and promising future revenue prospects for the company.
This analysis was generated using AI and real-time stock data. Always do your own research before making investment decisions.